Hosted on MSN2h
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.05 per share a year ago. These figures are ...
AngioDynamics Inc. Q2 Loss Decreases, Beats Estimates
AngioDynamics Inc. (ANGO) revealed Loss for second quarter that decreased from last year but beat the Street estimates. The ...
What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings
AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q2 2025 earnings on Jan 8, 2025. The consensus estimate for Q2 2025 ...
AngioDynamics: Fiscal Q2 Earnings Snapshot
AngioDynamics expects full-year earnings in the range of 34 cents to 38 cents per share, with revenue in the range of $282 million to $288 million. AngioDynamics shares have risen roughly 3% since the ...
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife(TM) System
Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...
Vanguard10d
Michael Ango: Revolutionizing revenue assurance in the FCT
In August 2024, President Bola Ahmed Tinubu appointed Mr. Michael Hadi Ango as the Acting Executive Chairman of the Federal ...
TheCable8d
Michael Ango: Revolutionising revenue assurance in the FCT
In a bold move to improve efficiency, Ango initiated the takeover of revenue collection for the FCT’s area councils by the FCT-IRS. This centralization effort is designed to minimize leakages and ...